CymitQuimica logo

Selonsertib

CAS:

Ref. 3D-FC157241

5mg
Discontinued
0.1g
Discontinued
10mg
Discontinued
25mg
Discontinued
50mg
Discontinued
0.01g
Discontinued
0.05g
Discontinued
100mg
Discontinued
250mg
Discontinued
0.025g
Discontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .

Selonsertib
Biosynth

Product Information

Name:Selonsertib
Synonyms:
  • 5-(4Cyclopropyl- 1H- imidazol- 1- yl) - 2- fluoro- N- (6- (4- isopropyl- 4H- 1
  • 2
  • 4- triazol- 3- yl) pyridin- 2- yl) - 4- methylben zamide
Brand:Biosynth
Description:Selonsertib is a highly selective inhibitor of the ATP-binding cassette transporter (ABCA1) that belongs to the class of glp-1 analogues. It is used in combination with other drugs for the treatment of bowel disease, autoimmune diseases, and skin cancer. Selonsertib has been shown to be active against a number of cell types and is also effective in models of metabolic disorders such as hepatic steatosis and kidney fibrosis. Selonsertib blocks ABCA1 by binding to its ATP-binding site, inhibiting cholesterol efflux from cells. This drug may work by restoring mitochondrial membrane potential, which may help prevent or reverse cellular damage caused by oxidative stress.
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:445.49 g/mol
Formula:C24H24FN7O
Purity:Min. 95%
InChI:InChI=1S/C24H24FN7O/c1-14(2)32-13-27-30-23(32)19-5-4-6-22(28-19)29-24(33)17-10-21(15(3)9-18(17)25)31-11-20(26-12-31)16-7-8-16/h4-6,9-14,16H,7-8H2,1-3H3,(H,28,29,33)
InChI key:InChIKey=YIDDLAAKOYYGJG-UHFFFAOYSA-N
SMILES:Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)cc1-n1cnc(C2CC2)c1

Inquiry about discontinued product: Selonsertib

◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.